Publications

5891 Results

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: prospective combined analysis of phase III trials investigating duration of adjuvant therapy with the FOLFOX (FOLFOX4 or modified FOLFOX6) or XELOX (3 versus 6 months) regimen for patients with stage III colon cancer: trial design and current status

Authors
T Andre;T Iveson;R Labianca;JA Meyerhardt;I Souglakos;T Yoshino;J Paul;A Sobrero;J Taieb;A Shields;A Ohtsu;A Grothey;DJ Sargent
Journal / Conference
Current Colorectal Cancer Reports 9:261-269
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID24032000
PMC
PMC3766516
Study Number(s)
CTSU/C80702

Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: findings from CALGB 89803/Alliance

Authors
J Jeon;K Sato;D Niedzwiecki;X Ye;LB Saltz;RJ Mayer;RB Mowat;R Whittom;H Hantel;A Benson;D Wigler;D Atienza;M Messino;H Kindler;A Venook;C Fuchs;J Meyerhardt
Journal / Conference
Clinical Colorectal Cancer 12(4):233-238;
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID24035029
PMC
PMC3818492
Study Number(s)
C89803

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

Authors
GD Goss;C O'Callaghan;I Lorimer;MS Tsao;GA Masters;J Jett;MJ Edelman;R Lilenbaum;AH Choy;F Khuri;K Pisters;D Gandara;K Kernstine;C Butts;J Noble;TA Hensing;K Rowland;J Schiller;K Ding;FA Shepherd
Journal / Conference
Journal of Clinical Oncology 31(27):3320-3326;
Year
2013
Research Committee(s)
Lung
PMID
PMID23980091
PMC
PMC3770864

Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database

Authors
Q Shi;T Andre;A Grothey;G Yothers;SR Hamilton;BM Bot;DG Haller;E van Cutsem;C Twelves;J Benedetti;MJ O'Connell;DJ Sargent
Journal / Conference
Journal of Clinical Oncology 31(29):3656-3663
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID23980089
PMC
PMC3804289
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Future perspectives in melanoma research:Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"

Authors
PA Ascierto;AM Grimaldi;N Acquavella;L Borgognoni;L Calabro;N Cascinelli;A Cesano;M Del Vecchio;AM Eggermont;M Faries;S Ferrone;BA Fox;T Gajewski;J Galon;S Gnjatic;H Gogas;M Kashani-Sabet;HL Kaufman;J Larkin;RS Lo;A Mantovani;K Margolin;C Melief;G McArthur;G Palmieri;I Puzanov;A Ribas;B Seliger;J Sosman;P Suenaert;A Tarhini;G Trinchieri;F Vidal-Vanaclocha;E Wang;G Ciliberto;N Mozzillo;FM Marincola;M Thurin
Journal / Conference
Journal of Translational Medicine 11:137
Year
2013
Research Committee(s)
Melanoma
PMID
PMID23731854
PMC
PMC3681569
Study Number(s)
S0008, SWOG-9348

Novel approaches to treatment of double-refractory multiple myeloma

Authors
HC Lee;JJ Shaw;RZ Orlowski
Journal / Conference
Society of Clinical Oncology Education Book p. 302-306, 2013
Year
2013
Research Committee(s)
Myeloma
PMID
PMID23714530
PMC
PMC3762449

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry

Authors
KL Monda;GK Chen;KC Taylor;C Palmer;TL Edwards;LA Lange;MC Ng;AA Adeyemo;MA Alllison;LF Bielak;G Chen;MR Graff;MR Irvin;SK Rhie;G Li;Y Liu;Y Liu;Y Lu;M Nalls;YV Sun;MK Wojczynski;LR Yanek;MC Aldrich;A Ademola;CI Amos;EV Bandera;CH Bock;A Britton;U Broeckel;Q Cai;NE Caporaso;CS Carlson;J Carpten;G Casey;WN Chen;YD Chen;CW Chiang;GA Coetzee;E Demarath;SL Deming-Halverson;RW Driver;P Dubbert;M Feitosa;Y Feng;BI Freedman;EM Gillanders;O Gottesman;X Guo;T Haritunians;T Harris;CC Harris;AJ Hennis;DG Hernandez;LH McNeill;TD Howard;BV Howard;VJ Howard;KC Johnson;SJ Kang;BJ Keating;S Kolb;LH Kuller;A Kutlar;CD Langefeld;G Lettre;K Lohman;V Lotay;H Lyon;JE Manson;W Maixner;YA Meng;KR Monroe;I Morhason-Bello;AB Murphy;JC Mychaleckyj;R Nadukuru;K Nathanson;U Nayak;A N'diaye;B Nemesure;SY Wu;MC Leske;C Neslund-Dudas;M Neuhouser;S Nyante;H Ochs-Balcom;A Ogunniyi;TO Ogundiran;O Ojengbede;O Olopade;JR Palmer;R Ruiz-Narvaez;ND Palmer;M Press;E Rampersaud;LJ Rasmussen-Torvik;JL Rodriguez-Gil;B Salako;EE Schadt
Journal / Conference
Nature Genetics 45(6):690-696
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID23583978
PMC
PMC3694490
Study Number(s)
S0000

Novel long-term co-culture approach identifies prognostically important heterogeneity of stem/progenitor cell involvement in human acute myeloid leukemia

Authors
GS Laszlo;JM Lionberger;BS Harrington;CJ Gudgeon;M Othus;F Appelbaum;ID Bernstein;R Walter
Journal / Conference
Blood 122:1318; ASH annual meeting, poster presentaton
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Azacitidine with our without entinostat for the treatment of therapy related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Authors
T Prebet;Z Sun;R Ketterling;P Greenberg;A Zeidan;M Litzow;J Gabriolove;H Erba;E Paietta;M Czader;SD Gord;M Tallman
Journal / Conference
Blood 122:3924, ASH annual meeting, poster presentation;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
E1905

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

Authors
R Thariani;NL Henry;S Ramsey;DK Blough;W Barlow;J Gralow;D Veenstra
Journal / Conference
Journal of Comparative Effectiveness Research 2(3):325-334
Year
2013
Research Committee(s)
Breast
PMID
PMID24236631
PMC
PMC4018420
Study Number(s)
S1007